These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30621649)

  • 1. Combination therapy with erythropoietin, magnesium sulfate and hypothermia for hypoxic-ischemic encephalopathy: an open-label pilot study to assess the safety and feasibility.
    Nonomura M; Harada S; Asada Y; Matsumura H; Iwami H; Tanaka Y; Ichiba H
    BMC Pediatr; 2019 Jan; 19(1):13. PubMed ID: 30621649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnesium Sulfate as an Adjunct to Therapeutic Hypothermia in the Management of Term Infants with Hypoxic-Ischemic Encephalopathy: A Randomized, Parallel-Group, Controlled Trial.
    Kumar C; Adhisivam B; Bobby Z; Bhat BV
    Indian J Pediatr; 2023 Sep; 90(9):886-892. PubMed ID: 35849276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.
    Wu YW; Bauer LA; Ballard RA; Ferriero DM; Glidden DV; Mayock DE; Chang T; Durand DJ; Song D; Bonifacio SL; Gonzalez FF; Glass HC; Juul SE
    Pediatrics; 2012 Oct; 130(4):683-91. PubMed ID: 23008465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial.
    Wu YW; Mathur AM; Chang T; McKinstry RC; Mulkey SB; Mayock DE; Van Meurs KP; Rogers EE; Gonzalez FF; Comstock BA; Juul SE; Msall ME; Bonifacio SL; Glass HC; Massaro AN; Dong L; Tan KW; Heagerty PJ; Ballard RA
    Pediatrics; 2016 Jun; 137(6):. PubMed ID: 27244862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL): A Randomized Controlled Trial - Background, Aims, and Study Protocol.
    Juul SE; Comstock BA; Heagerty PJ; Mayock DE; Goodman AM; Hauge S; Gonzalez F; Wu YW
    Neonatology; 2018; 113(4):331-338. PubMed ID: 29514165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose erythropoietin population pharmacokinetics in neonates with hypoxic-ischemic encephalopathy receiving hypothermia.
    Frymoyer A; Juul SE; Massaro AN; Bammler TK; Wu YW
    Pediatr Res; 2017 Jun; 81(6):865-872. PubMed ID: 28099423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of seizures in neonates with hypoxic-ischemic encephalopathy receiving hypothermia plus erythropoietin or placebo.
    Glass HC; Wusthoff CJ; Comstock BA; Numis AL; Gonzalez FF; Maitre N; Massey SL; Mayock DE; Mietzsch U; Natarajan N; Sokol GM; Bonifacio SL; Van Meurs KP; Thomas C; Ahmad KA; Heagerty PJ; Juul SE; Wu YW
    Pediatr Res; 2023 Jul; 94(1):252-259. PubMed ID: 36470964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single dose recombinant erythropoietin versus moderate hypothermia for neonatal hypoxic ischemic encephalopathy in low resource settings.
    El Shimi MS; Awad HA; Hassanein SM; Gad GI; Imam SS; Shaaban HA; El Maraghy MO
    J Matern Fetal Neonatal Med; 2014 Sep; 27(13):1295-300. PubMed ID: 24134405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns.
    Wu YW; Comstock BA; Gonzalez FF; Mayock DE; Goodman AM; Maitre NL; Chang T; Van Meurs KP; Lampland AL; Bendel-Stenzel E; Mathur AM; Wu TW; Riley D; Mietzsch U; Chalak L; Flibotte J; Weitkamp JH; Ahmad KA; Yanowitz TD; Baserga M; Poindexter BB; Rogers EE; Lowe JR; Kuban KCK; O'Shea TM; Wisnowski JL; McKinstry RC; Bluml S; Bonifacio S; Benninger KL; Rao R; Smyser CD; Sokol GM; Merhar S; Schreiber MD; Glass HC; Heagerty PJ; Juul SE;
    N Engl J Med; 2022 Jul; 387(2):148-159. PubMed ID: 35830641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy.
    Rogers EE; Bonifacio SL; Glass HC; Juul SE; Chang T; Mayock DE; Durand DJ; Song D; Barkovich AJ; Ballard RA; Wu YW
    Pediatr Neurol; 2014 Nov; 51(5):657-62. PubMed ID: 25439577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy: magnetic resonance imaging findings and neurological outcomes in a Brazilian cohort.
    Procianoy RS; Corso AL; Longo MG; Vedolin L; Silveira RC
    J Matern Fetal Neonatal Med; 2019 Aug; 32(16):2727-2734. PubMed ID: 29504433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot cohort study of cerebral autoregulation and 2-year neurodevelopmental outcomes in neonates with hypoxic-ischemic encephalopathy who received therapeutic hypothermia.
    Burton VJ; Gerner G; Cristofalo E; Chung SE; Jennings JM; Parkinson C; Koehler RC; Chavez-Valdez R; Johnston MV; Northington FJ; Lee JK
    BMC Neurol; 2015 Oct; 15():209. PubMed ID: 26486728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and Safety of Therapeutic Hypothermia and Short Term Outcome in Neonates with Hypoxic Ischemic Encephalopathy.
    Purkayastha J; Lewis LE; Bhat RY; Anusha KM
    Indian J Pediatr; 2016 Feb; 83(2):175-7. PubMed ID: 26141549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy.
    Zhu C; Kang W; Xu F; Cheng X; Zhang Z; Jia L; Ji L; Guo X; Xiong H; Simbruner G; Blomgren K; Wang X
    Pediatrics; 2009 Aug; 124(2):e218-26. PubMed ID: 19651565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination treatments with therapeutic hypothermia for hypoxic-ischemic neuroprotection.
    Zhou KQ; Davidson JO; Bennet L; Gunn AJ
    Dev Med Child Neurol; 2020 Oct; 62(10):1131-1137. PubMed ID: 32614467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral oxygen metabolism during and after therapeutic hypothermia in neonatal hypoxic-ischemic encephalopathy: a feasibility study using magnetic resonance imaging.
    Shetty AN; Lucke AM; Liu P; Sanz Cortes M; Hagan JL; Chu ZD; Hunter JV; Lu H; Lee W; Kaiser JR
    Pediatr Radiol; 2019 Feb; 49(2):224-233. PubMed ID: 30402807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment.
    Yıldız EP; Ekici B; Tatlı B
    Expert Rev Neurother; 2017 May; 17(5):449-459. PubMed ID: 27830959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Short-Term Outcomes of Therapeutic Hypothermia in Preterm Neonates 34-35 Weeks Gestational Age with Hypoxic-Ischemic Encephalopathy.
    Rao R; Trivedi S; Vesoulis Z; Liao SM; Smyser CD; Mathur AM
    J Pediatr; 2017 Apr; 183():37-42. PubMed ID: 27979578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Size, Maturation, Global Asphyxia, Cerebral Ischemia, and Therapeutic Hypothermia on the Pharmacokinetics of High-Dose Recombinant Erythropoietin in Fetal Sheep.
    Dhillon SK; Wassink G; Lear CA; Davidson JO; Holford NHG; Gunn AJ; Bennet L
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of therapeutic hypothermia in neonates with mild hypoxic-ischemic encephalopathy.
    Wang Z; Zhang D; Zhang P; Zhou W; Hu L; Wang L; Cheng G
    BMC Pediatr; 2023 Oct; 23(1):530. PubMed ID: 37884911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.